GSK Partners with Ministry of Public Health to Expand Research Investment in Thailand by 1.5 Billion Baht

Published 2026-11-07

GSK, a global biopharmaceutical company, together with the Ministry of Public Health (MoPH), has announced an expansion of its research investment in Thailand worth 1.5 billion baht, with an implementation period of 10 years. The collaboration is driven through the Medical Investment Hub, a mechanism that promotes investment in medicine and public health in the country.

This investment focuses on medical research and the development of health products, which are an important part of the country's public health system. Expanding research in Thailand gives Thai researchers and medical personnel more opportunities to work alongside international experts.

Public-private partnerships of this kind demonstrate a joint effort to develop health research. Experts believe that research investment may help advance Thailand's medical knowledge and technology, and also create employment opportunities in science and medicine in the long term.

However, at this time there are no further details about the sub-projects or the implementation schedule for each stage. Interested members of the public can follow the project's progress through press releases from the Ministry of Public Health and GSK.

Sources: bangkokbiznews

More Thailand news

All Thailand news · News by country